162046-38-0

Basic information

• Product Name: 1-tert-butyloxycarbonyl-4-trimethylstannyl-1,2,5,6-tetrahydropyridine
• Synonyms: 1-tert-butyloxycarbonyl-4-trimethylstannyl-1,2,5,6-tetrahydropyridine
• CAS NO: 162046-38-0
• Molecular Weight: 346.057
• Mol File: 162046-38-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-tert-butyloxycarbonyl-4-trimethylstannyl-1,2,5,6-tetrahydropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-tert-butyloxycarbonyl-4-trimethylstannyl-1,2,5,6-tetrahydropyridine(162046-38-0)
• EPA Substance Registry System: 1-tert-butyloxycarbonyl-4-trimethylstannyl-1,2,5,6-tetrahydropyridine(162046-38-0)

Safety Data

• Hazardous Substances Data: 162046-38-0(Hazardous Substances Data)

Upstream product

• 610-36-6 4-amino-2-nitrobenzoic acid 

Downstream Products

• 138647-53-7 1-tert-butyloxycarbonyl-4-(4-methylphenyl)-1,2,3,6-tetrahydropyridine 
• 1555377-05-3 tert-butyl 4-benzoyl-3,6-dihydro-2H-pyridine-1-carboxylate 
• 301220-83-7 4-((5-benzyl)pyrid-3-yl)piperidine, trifluoroacetate salt 
• 252330-19-1 5(R)-Isoxazol-3-yloxymethyl-3-(4-(1-tert-butoxycarbonyl-1,2,5,6-tetrahydropyrid-4-yl)phenyl)oxazolidin-2-one 
• 782493-45-2 tert-butyl 4-[4-fluoro-3-(methoxycarbonyl)phenyl]-3,6-dihydropyridine-1(2H)-carboxylate 
• 301220-82-6 C₁₇H₂₀N₂ 
• 607744-56-9 tert-butyl 4-(4-chloro-2-methoxyphenyl)-3,6-dihydropyridine-1(2H)-carboxylate 
• 607744-53-6 tert-butyl 4-{4-[acetyl(benzyl)amino]phenyl}-3,6-dihydropyridine-1(2H)-carboxylate 
• 906463-12-5 4-[5-(2-chloro-phenyl)-1-(2,6-dichloro-phenyl)-2-oxo-1,2,3,4-tetrahydro-pyrido[4,3-d]pyrimidin-7-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 444663-63-2 7-(1-tert-butoxycarbonyl-1,2,3,6-tetrahydro-4-pyridinyl)-5-(2-chloro-4-fluorophenyl)-1-(2,6-dichlorophenyl)-3,4-dihydro-2(1H)-quinolinone 
• 444664-31-7 4-[1-(2,6-dichloro-phenyl)-5-(2,4-difluoro-phenyl)-2-oxo-1,2,3,4-tetrahydro-quinazolin-7-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 444665-23-0 tert-butyl 4-[5-(2-chlorophenyl)-1-(2,6-dichlorophenyl)-2-oxo-1,2-dihydroquinolin-7-yl]-3,6-dihydropyridine-1(2 H)-carboxylate 

Relevant articles and documents

Combination therapy with CHK1 inhibitors

Compounds of Structure I, and salts, tautomers, stereoisomers, and mixtures thereof may be used in methods of inhibiting checkpoint kinase 1 in subjects, in methods for inducing cell cycle progression, and in methods for increasing apoptosis in cells. Such compounds may be used to prepare pharmaceutical compositions and may be used in conjunction with DNA damaging agents.